| Issue |
BIO Web Conf.
Volume 135, 2024
4th International Conference on Pharmaceutical Updates (ICPU 2024)
|
|
|---|---|---|
| Article Number | 02002 | |
| Number of page(s) | 6 | |
| Section | Treatment Evaluation Updates | |
| DOI | https://doi.org/10.1051/bioconf/202413502002 | |
| Published online | 07 November 2024 | |
BersaMaDia App for Improving Quality of Life in Type 2 Diabetes Mellitus Patients at Asri Medical Center Muhammadiyah Hospital Yogyakarta
1 School of Pharmacy, Faculty of Medicine and Health Sciences, Universitas Muhammadiyah Yogyakarta, Indonesia
2 Department of Pharmacy, Asri Medical Center, Yogyakarta, Indonesia
3 Department of Internist, Asri Medical Center, Yogyakarta, Indonesia
4 School of Medicine, Faculty of Medicine and Health Sciences, Universitas Muhammadiyah Yogyakarta, Indonesia
5 School of Nursing, Faculty of Medicine and Health Sciences, Universitas Muhammadiyah Yogyakarta, Indonesia
* Corresponding author: pinasti.utami@umy.ac.id
Type 2 diabetes mellitus is a major health problem worldwide that can cause impairment in quality of life. One of the efforts that can be made to improve quality of life is by providing education to patients. In the current era of digitalization, health services can use the concept of e-health which focuses on diabetes self-management. BersaMaDia mobile application is the implementations of the e-health concept created through interprofessional collaboration. This study objective is to evaluate the improvement in the quality of life of diabetes mellitus patients by using the BersaMaDia application at Asri Medical Center Muhammadiyah Hospital Yogyakarta. This study is a pre-experimental study with a one group pre-post design. A total of 30 patients were given an intervention using the BersaMaDia application for 1 month. Measurement of patients’ quality of life pre and post the intervention using the diabetes quality of life clinical trial questionnaire (DQLCTQ) which includes 8 domains. Data were statistically analyzed with SPSS using paired sample t-test. The results showed that there was a difference in the average quality of life pre and after the intervention with an average score of 26.98 and 33.57 respectively (p value 0.000). The use of the BersaMaDia application can improve the quality of life in patients with type 2 diabetes mellitus immediately after 1 month of using the application.
© The Authors, published by EDP Sciences, 2024
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.